Editors' highlights: Skin Cancer Awareness Month

May is Skin Cancer Awareness Month, dedicated to raising awareness about skin cancer and promoting early diagnosis and treatment.

 Environmental changes, aging, and genetic modifications are contributing to the rising number of skin cancer cases. Early detection and treatment significantly improve patient outcomes.

To promote Skin Cancer Awareness Month , we have curated articles discussing the current status of skin cancer, its various factors, and the latest treatments.

BJC Reports

• Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study

Biomarker Research

• ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

Experimental Hematology & Oncology

• LINP1 represses unfolded protein response by directly inhibiting eIF2α phosphorylation to promote cutaneous squamous cell carcinoma

• Secretogranin II influences the assembly and function of MHC class I in melanoma

Molecular Cancer

• Advancements in nanoparticle-based treatment approaches for skin cancer therapy

• ERK mediates interferon gamma-induced melanoma cell death

Cancer Cell International

• Melanoma biology and treatment: a review of novel regulated cell death-based approaches

• It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort